CN
  • About Microdiag great health
  • Early screening project
  • Great health news
  • User story
  • Service support
  • Report query
  • About Microdiag great health

    The Microdiag Big Health Division is committed to screening major chronic diseases such as tumors and liver damage, providing "high-risk group" screening services from healthy individuals to disease populations. By deeply cultivating private chain physical examinations and chain clinical examination channels for special inspections, we aim to select innovative products and achieve full channel development of toB and toC.


    Currently operating a testing product with NMPA approval: the new colon cancer label "Wei Changwei" ®” CST4, New Molecular Indicator for Colon Cancer Blood Test "Chang Jiu'an ®” Septin9, a new indicator for pan cancer screening, "Dopplectra" DR-70. As well as the new index sH2a of liver disease screening, lung screening product "clear lung", multi tumor liquid biopsy ultra early screening "preMeD", AD, bladder cancer cancer, prostate cancer, cervical cancer and other innovative screening products.


    Relying on cutting-edge scientific research capabilities and numerous technological reserves, we have formed a product line for screening major chronic diseases such as tumors and liver damage, in order to meet the needs of different markets.


    At present, the business has covered areas such as the Yangtze River Delta, Pearl River Delta, and Beijing Tianjin Hebei. The diversification of our product structure enables us to serve a wider and more diverse customer base. We will adhere to our mission of providing innovative screening solutions for major disease warnings, and continuously strive to become a leading brand in major chronic disease screening fields such as early screening of tumors and liver and kidney injuries. Our goal is to enable our customers to "afford and enjoy" the highest quality products and services.

    Market strategy
  • Dedicated to screening major chronic diseases such as tumors and liver and kidney damage
  • Deeply cultivate the channels for private chain physical examinations and chain clinical examinations
  • Optimizing innovative products to achieve full channel development of ToB and ToC
  • Mission

    Provide innovative screening solutions for major disease warning

  • Vision

    Becoming a leading brand for major disease warning and screening

  • Culture

    Innovation and win-win

  • Slogan

    Accurate prevention, early screening first

  • Hotline: 0512-8187-9848

    Address: Building 16, Northwest District, Suzhou Nano City, No. 99, Jinji Lake Avenue, Suzhou Industrial Park, Jiangsu Province